Fertilizers & Chemicals Travancore Ltd
FACTFertilizers & Chemicals Travancore Ltd's price has outrun its earnings. −11.4% in a year against EPS −67.7% — the market is paying now for delivery later.
The sharpest disagreement: the price moved −11.4% in a year while annual EPS moved −67.7% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (10 weeks in) while the P/E sits at the 94th percentile of its own 6-year range. Underneath, the last four quarters read deteriorating — profit −950.0% year on year, and 135% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Fertilizers & Chemicals Travancore Ltd trades at ₹827, in a confirmed uptrend and 10 weeks into that stage. That is −3.9% against its own 200-day average. It sits at 46% of a 52-week range of ₹681 to ₹1,000. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (8 weeks and counting).
Today the stock is in a confirmed uptrend — week 10 of stage 2. At ₹827 it trades −3.9% versus its 200-day average and sits at 46% of its 52-week range (₹681–₹1,000).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +3,827% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (8 weeks and counting; last ahead the week of 2026-06-19) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Fertilizers & Chemicals Travancore Ltd trades at 3,612.0× P/E, at the pricey end of its own range (94th percentile). Its long-run median P/E is 48.4×, measured across 5.9 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 3,612.0× is at the pricey end of its own range (94th percentile), against a long-run median of 48.4× measured over 5.9 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −67.7% against a −11.4% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the +42.4%/yr price move, ~−46.9%/yr came from earnings growth and ~+89.3 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Fertilizers & Chemicals Travancore Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −113.6% at the trough to +276.0%, a 2-quarter improving streak, ROCE holding at 18.8%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −19.8% | −2.9% | +7.9% | +7.4% |
| Profit | −68.0% | −50.9% | −47.0% | — |
| EPS | −67.7% | −50.7% | −46.8% | — |
| Share price | −11.4% | +20.1% | +42.4% | +42.5% |
4-Factor Sector Score
37.0/100 — rank 15 of 15 in Fertilisers · 89% evidence confidence
Fertilizers & Chemicals Travancore Ltd scores 37.0 out of 100 against the 15 companies it is compared with in Fertilisers, ranking 15. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 17.5 + 4.2 + 5 + 10.3 = 37. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Fertilizers & Chemicals Travancore Ltd reported ₹1,568 Cr of revenue in the Dec 25 quarter, +65.2% year on year. That is the 3rd straight quarter of year-on-year growth. Over 10 years it has compounded at 7.4% a year. The last full year, FY25, came in at ₹4,051 Cr. The last four reported quarters add to ₹5,293 Cr.
FY25 revenue came in at ₹4,051 Cr (−19.8% on the year), capping 10 years at 7.4% compound. The latest quarter (Dec 25) printed ₹1,568 Cr, +65.2% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +37.7% growth against the decade's 7.4% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +30.4% over the last 4 quarters against +0.5%/yr over the last 8 — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Fertilizers & Chemicals Travancore Ltd's operating margin is −2.7% in the Dec 25 quarter, −6.0 percentage points against the same quarter a year ago. Across 11 fiscal years the operating margin has ranged −13.0% to 17.0%. The current quarter sits inside that band.
The latest quarter's operating margin is −2.7%, −6.0 pp against the same quarter a year ago. Across 11 fiscal years the operating margin has ranged −13.0%–17.0%.
🚨 Why the margin moved: operating margin went −6.0 pp year on year while gross margin went −13.1 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Fertilizers & Chemicals Travancore Ltd posted a net loss of ₹68.0 Cr in the Dec 25 quarter. Full-year FY25 profit was ₹41.0 Cr. That loss is 4.3% of the quarter's revenue. The same quarter a year earlier earned ₹8.0 Cr. 3 of the last 12 reported quarters were loss-making.
Dec 25 profit was ₹−68.0 Cr, −950.0% year on year. On the full year, FY25 printed ₹41.0 Cr (−68.0%).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 135% of Fertilizers & Chemicals Travancore Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY25 that was ₹140 Cr of operating cash against ₹41.0 Cr of profit. After ₹153 Cr of capital spending, ₹−13.0 Cr was left as free cash.
FY25: operating cash of ₹140 Cr against reported profit of ₹41.0 Cr, leaving free cash of ₹−13.0 Cr after ₹153 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 135% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 135%: the cash cycle tightened 47 days between FY20 and FY25 — cash that used to wait in the cycle now reaches the bank sooner.
Router verdict: the bigger cash user is investment — capital spending ran 4.3× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Fertilizers & Chemicals Travancore Ltd's cash conversion cycle runs 94 days in FY25, down from 141 days in FY20. Capital spending ran ₹402 Cr over the last 3 years. At FY25 sales of ₹4,051 Cr each day of that cycle holds about ₹11.1 Cr, so roughly ₹1,043 Cr sits inside the business at any moment.
FY25: debtors at 26 days, inventory at 128 days — roughly 4.2 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 94 days, tighter than FY20's 141.
The full loop: cash goes out to suppliers and production on day 0; stock waits 128 days to sell; customers pay about 26 days after that; and suppliers themselves are paid at 60 days — netting out to the 94-day cycle.
In money terms: at FY25 sales of ₹4,051 Cr, each day of the cycle holds about ₹11.1 Cr — so the 94-day loop keeps roughly ₹1,043 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹402 Cr over the last 3 fiscal years against ₹94.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹216 Cr (FY25) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Fertilizers & Chemicals Travancore Ltd earns a ROCE of 9% in FY25. That is up from a trough of −55% in FY16. Return on invested capital clears the cost of that capital by −10.3 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 1.0% net margin on 0.67× asset turns.
FY25 ROCE is 9%, recovered from a FY16 trough of −55% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY25): 1.0% net margin × 0.67× asset turns × 4.40× balance-sheet leverage ≈ 2.9% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 1.7% − 12.0% = a −10.3 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Fertilizers & Chemicals Travancore Ltd carries total debt of ₹3,985 Cr against shareholder equity of ₹1,350 Cr as of Mar 26, a debt-to-equity of 2.95. On the annual view that ratio went from 2.78 in FY22 to 2.95 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹3,985 Cr against shareholder equity of ₹1,350 Cr — a debt-to-equity of 2.95. On the annual view, debt-to-equity went from 2.78 (FY22) to 2.95 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Domestic institutions cut 8.5 points of Fertilizers & Chemicals Travancore Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 0.1% of the company. Promoters moved +0.0 points over the same window, to 90.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: −8.5 points over 8 quarters to 0.1%; Promoters: +0.0 points over 8 quarters to 90.0%; Foreign institutions: +0.0 points over 8 quarters to 0.2%.
🚨 Why the register moved: domestic institutions drove it (−8.5 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Fertilizers & Chemicals Travancore Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Gujarat Narmada Valley Fertilizers & Chemicals LtdGNFC | 69.5/100Favorable setup96% evidence | BREAKING OUT | 21.1/35 Revenue -1.5% · PAT 35.3% · OPM change 10 pp 88% evidence | 14.3/25 ROCE 12% · OPM 22% 100% evidence | 15.1/20 P/E 9.3× · PEG 0.27 100% evidence | 19.0/20 RS sector 11.8% · RS bench 3.1% · 1Y -5.2%10 of 12 weeks ahead 100% evidence |
| Exact sum: 21.1 + 14.3 + 15.1 + 19 = 69.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Krishana Phoschem LtdKRISHANA | 66.9/100Favorable setup100% evidence | BASING | 28.7/35 Revenue 73.3% · PAT 92.2% · OPM change 0 pp 100% evidence | 18.9/25 ROCE 27.2% · OPM 17% 100% evidence | 13.9/20 P/E 28.8× · PEG 0.58 100% evidence | 5.4/20 RS sector -54.9% · RS bench 56.5% · 1Y -65.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 28.7 + 18.9 + 13.9 + 5.4 = 66.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -54.9% and the one-year return is -65.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3Chambal Fertilisers & Chemicals LtdCHAMBLFERT | 66.3/100Favorable setup100% evidence | ASLEEP | 17.1/35 Revenue 15.6% · PAT 10.2% · OPM change 3 pp 100% evidence | 18.9/25 ROCE 25.5% · OPM 16% 100% evidence | 17.0/20 P/E 9.1× · PEG 0.52 100% evidence | 13.3/20 RS sector 0.4% · RS bench -7.8% · 1Y -18.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 18.9 + 17 + 13.3 = 66.3 · Decision use: Price leads the evidence: RS versus the benchmark is -7.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 4Rashtriya Chemicals & Fertilizers LtdRCF | 51.2/100Mixed-positive evidence90% evidence | ASLEEP | 21.9/35 Revenue 9.1% · PAT 76.5% · OPM change 1.2 pp 88% evidence | 7.5/25 ROCE 10.2% · OPM 6% 100% evidence | 12.6/20 P/E 17.8× · PEG 0.9 100% evidence | 9.2/20 RS sector -3.1% · RS bench -7.8% · 1Y -16.7%3 of 10 weeks ahead 70% evidence |
| Exact sum: 21.9 + 7.5 + 12.6 + 9.2 = 51.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Khaitan Chemicals & Fertilizers LtdKHAICHEM | 51.1/100Mixed-positive evidence74% evidence | 20.6/35 Revenue 19.9% · PAT 32.5% · OPM change -3 pp 95% evidence | 15.6/25 ROCE 18.5% · OPM 11% 95% evidence | 11.1/20 P/E 8.2× · PEG — 15% evidence | 3.8/20 RS sector -31.3% · RS bench -38.4% · 1Y -57.1%1 of 8 weeks ahead 70% evidence | |
| Exact sum: 20.6 + 15.6 + 11.1 + 3.8 = 51.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Paradeep Phosphates LtdPARADEEP | 51.1/100Mixed-positive evidence69% evidence | TURNING | 19.4/35 Revenue 28.1% · PAT 12.6% · OPM change -1 pp 95% evidence | 14.3/25 ROCE 17.1% · OPM 12% 76% evidence | 10.0/20 P/E 14.1× · PEG — 15% evidence | 7.4/20 RS sector -12.4% · RS bench -2.6% · 1Y -22.2%6 of 10 weeks ahead 70% evidence |
| Exact sum: 19.4 + 14.3 + 10 + 7.4 = 51.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Madhya Bharat Agro Products LtdMBAPL | 50.3/100Mixed-positive evidence100% evidence | BASING | 24.3/35 Revenue 47.6% · PAT 100% · OPM change 2 pp 100% evidence | 16.1/25 ROCE 19.3% · OPM 16% 100% evidence | 4.5/20 P/E 45.3× · PEG 2.04 100% evidence | 5.4/20 RS sector -52.8% · RS bench 63.9% · 1Y -62.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.3 + 16.1 + 4.5 + 5.4 = 50.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -52.8% and the one-year return is -62.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 8Southern Petrochemicals Industries Corporation LtdSPIC | 49.6/100Mixed-negative evidence76% evidence | ASLEEP | 17.5/35 Revenue -4.2% · PAT 36.1% · OPM change 3.1 pp 83% evidence | 14.3/25 ROCE 17.5% · OPM 8% 95% evidence | 11.3/20 P/E 6.4× · PEG — 15% evidence | 6.5/20 RS sector -8.2% · RS bench -16.4% · 1Y -32.6%6 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 14.3 + 11.3 + 6.5 = 49.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Zuari Agro Chemicals LtdZUARI | 47.9/100Mixed-negative evidence81% evidence | ASLEEP | 15.9/35 Revenue -44% · PAT 100% · OPM change -1 pp 95% evidence | 9.9/25 ROCE 16.4% · OPM 10% 95% evidence | 14.6/20 P/E 3.2× · PEG — 50% evidence | 7.5/20 RS sector -6.9% · RS bench -10.8% · 1Y 9.8%2 of 10 weeks ahead 70% evidence |
| Exact sum: 15.9 + 9.9 + 14.6 + 7.5 = 47.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Gujarat State Fertilizers & Chemicals LtdGSFC | 46.8/100Mixed-negative evidence90% evidence | ASLEEP | 17.3/35 Revenue 14.8% · PAT 13.9% · OPM change -1 pp 88% evidence | 6.7/25 ROCE 7.2% · OPM 3.2% 100% evidence | 15.1/20 P/E 9.4× · PEG 0.3 100% evidence | 7.7/20 RS sector -5.5% · RS bench -11.8% · 1Y -21%0 of 10 weeks ahead 70% evidence |
| Exact sum: 17.3 + 6.7 + 15.1 + 7.7 = 46.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Deepak Fertilisers & Petrochemicals Corp LtdDEEPAKFERT | 45.9/100Mixed-negative evidence94% evidence | TURNING | 13.3/35 Revenue 13.6% · PAT -0.5% · OPM change 7 pp 100% evidence | 11.8/25 ROCE 11.6% · OPM 26% 100% evidence | 11.2/20 P/E 19.9× · PEG 0.52 100% evidence | 9.6/20 RS sector -11.5% · RS bench 15.9% · 1Y 1.2%10 of 10 weeks ahead 70% evidence |
| Exact sum: 13.3 + 11.8 + 11.2 + 9.6 = 45.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Coromandel International LtdCOROMANDEL | 44.8/100Mixed-negative evidence94% evidence | TURNING | 12.7/35 Revenue 23.5% · PAT -20.9% · OPM change -2 pp 100% evidence | 16.9/25 ROCE 22% · OPM 9% 100% evidence | 1.5/20 P/E 32.8× · PEG 2.69 100% evidence | 13.7/20 RS sector 5% · RS bench -4.6% · 1Y -15.1%0 of 10 weeks ahead 70% evidence |
| Exact sum: 12.7 + 16.9 + 1.5 + 13.7 = 44.8 · Decision use: Price leads the evidence: RS versus the benchmark is -4.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 13National Fertilizer LtdNFL | 41.7/100Mixed-negative evidence89% evidence | ASLEEP | 19.3/35 Revenue 8.7% · PAT 15.2% · OPM change 2 pp 88% evidence | 6.1/25 ROCE 9.1% · OPM 7% 100% evidence | 10.1/20 P/E 16.6× · PEG 1.39 65% evidence | 6.2/20 RS sector -6.9% · RS bench -14.8% · 1Y -27.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.3 + 6.1 + 10.1 + 6.2 = 41.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Madras Fertilizers LtdMADRASFERT | 38.9/100Mixed-negative evidence62% evidence | ASLEEP | 13.5/35 Revenue -9.5% · PAT 24.6% · OPM change 16 pp 62% evidence | 10.3/25 ROCE 14.8% · OPM 5% 95% evidence | 10.2/20 P/E 12.3× · PEG — 15% evidence | 4.9/20 RS sector -14.4% · RS bench -12.3% · 1Y -25.5%3 of 10 weeks ahead 70% evidence |
| Exact sum: 13.5 + 10.3 + 10.2 + 4.9 = 38.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Fertilizers & Chemicals Travancore Ltdthis pageFACT | 37.0/100Mixed-negative evidence89% evidence | ASLEEP | 17.5/35 Revenue 30.4% · PAT 100% · OPM change -5.6 pp 88% evidence | 4.2/25 ROCE 8.7% · OPM 2.4% 100% evidence | 5.0/20 P/E 3612× · PEG 2.49 65% evidence | 10.3/20 RS sector 1.8% · RS bench -6.4% · 1Y -13.7%5 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 4.2 + 5 + 10.3 = 37 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Fertilizers & Chemicals Travancore Ltd's share price today?
Fertilizers & Chemicals Travancore Ltd trades at ₹827, −11.4% over the past year. The company is valued at ₹53,490 Cr. The stock sits at 46% of its 52-week range of ₹681–₹1,000, −3.9% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 10 weeks in. — as of 31 July 2026.
What were Fertilizers & Chemicals Travancore Ltd's latest quarterly results?
Fertilizers & Chemicals Travancore Ltd reported revenue of ₹1,568 Cr and a net loss of ₹68.0 Cr for the Dec 25 quarter. Revenue rose 65.2% and profit fell 950.0% year on year. Earnings per share were ₹−1.05. The operating margin was −2.7%, 6.0 pp lower than a year earlier. — as of 31 July 2026.
What is Fertilizers & Chemicals Travancore Ltd's revenue?
Fertilizers & Chemicals Travancore Ltd reported revenue of ₹1,568 Cr in the Dec 25 quarter, +65.2% year on year. For the full FY25 fiscal year, revenue was ₹4,051 Cr (−19.8%). Over the last 10 years revenue compounded at 7.4% a year. — as of 31 July 2026.
What is Fertilizers & Chemicals Travancore Ltd's profit?
Fertilizers & Chemicals Travancore Ltd earned ₹−68.0 Cr of net profit in the Dec 25 quarter, −950.0% year on year. Full-year FY25 profit was ₹41.0 Cr. The operating margin ran −2.7% in the latest quarter. — as of 31 July 2026.
What is Fertilizers & Chemicals Travancore Ltd's market cap?
Fertilizers & Chemicals Travancore Ltd's market capitalisation is ₹53,490 Cr at a share price of ₹827. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Fertilizers & Chemicals Travancore Ltd's P/E ratio?
Fertilizers & Chemicals Travancore Ltd trades at a P/E of 3,612.0×, at the 94th percentile of its own 6-year range, against a long-run median of 48.4×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Fertilizers & Chemicals Travancore Ltd pay a dividend?
Yes — Fertilizers & Chemicals Travancore Ltd's dividend payout was 61% of profit in FY25, and it recorded a payout in 3 of its last 11 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Fertilizers & Chemicals Travancore Ltd overvalued?
On its own history, Fertilizers & Chemicals Travancore Ltd looks expensive against its own history: its P/E of 3,612.0× sits at the 94th percentile of its 6-year range (long-run median 48.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Fertilizers & Chemicals Travancore Ltd growing?
Not right now — Fertilizers & Chemicals Travancore Ltd's latest numbers are shrinking: latest-quarter revenue +65.2% year on year, profit −950.0%, and the margin −6.0 pp at −2.7%. The earnings engine currently reads: deteriorating — as of 31 July 2026.
How is Fertilizers & Chemicals Travancore Ltd performing?
Fertilizers & Chemicals Travancore Ltd is in a confirmed uptrend, 10 weeks in. Its latest quarter's revenue rose 65.2% and profit fell 950.0% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 8 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is Fertilizers & Chemicals Travancore Ltd in?
Turning around — profit growth swung from −113.6% at the trough to +276.0%, a 2-quarter improving streak, ROCE holding at 18.8%. The read comes from the last 12 quarters of growth (revenue growth +30.4% latest, profit growth +276.0% latest, eps growth +262.5% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is Fertilizers & Chemicals Travancore Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 10 of stage 2), trading −3.9% versus its 200-day average and at 46% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Fertilizers & Chemicals Travancore Ltd beating the market?
Not lately — on a trailing-13-week view Fertilizers & Chemicals Travancore Ltd is currently behind the NIFTY 500 (8 weeks and counting; last ahead the week of 2026-06-19), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +3,827% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.
Will Fertilizers & Chemicals Travancore Ltd's share price go up?
This page publishes no price forecast for Fertilizers & Chemicals Travancore Ltd. What it measures instead: the share price is ₹827, the price is in a confirmed uptrend 10 weeks in. Its P/E of 3,612.0× sits at the 94th percentile of its own 6-year range. — as of 31 July 2026.
Who owns Fertilizers & Chemicals Travancore Ltd?
Promoters hold 90.0% of Fertilizers & Chemicals Travancore Ltd, foreign institutions 0.2%, domestic institutions 0.1% and the public 0.8% (latest quarter). The biggest move on the register over the last two years: Domestic institutions cut 8.5 points over 8 quarters. — as of 31 July 2026.
Does Fertilizers & Chemicals Travancore Ltd have too much debt?
It carries real leverage — Fertilizers & Chemicals Travancore Ltd's debt-to-equity is 1.32, and operating profit covers the interest bill 0×. FY25 borrowings were ₹1,805 Cr against equity of ₹1,371 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.
What is Fertilizers & Chemicals Travancore Ltd's capex?
Fertilizers & Chemicals Travancore Ltd spent ₹402 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was ₹153 Cr, with ₹216 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Fertilizers & Chemicals Travancore Ltd's cash flow?
Fertilizers & Chemicals Travancore Ltd generated ₹140 Cr of operating cash flow in FY25 and ₹−13.0 Cr of free cash flow after ₹153 Cr of capital spending. Reported profit that year was ₹41.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Fertilizers & Chemicals Travancore Ltd's profit real cash?
Yes — over the last 3 fiscal years, 135% of Fertilizers & Chemicals Travancore Ltd's reported profit arrived as operating cash. In FY25, operating cash was ₹140 Cr against reported profit of ₹41.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is Fertilizers & Chemicals Travancore Ltd in its business cycle?
Fertilizers & Chemicals Travancore Ltd's FY25 operating margin was 2.3%, against a 11-year band of −13.0%–17.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran −2.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Fertilizers & Chemicals Travancore Ltd story?
The sharpest disagreement: the price moved −11.4% in a year while annual EPS moved −67.7% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Fertilizers & Chemicals Travancore Ltd a stock worth studying right now?
This is not investment advice. The machine read: Fertilizers & Chemicals Travancore Ltd's price has outrun its earnings. −11.4% in a year against EPS −67.7% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.